NEURONETICS

neuronetics-logo

Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment.

#SimilarOrganizations #People #Financial #Website #More

NEURONETICS

Social Links:

Industry:
Biotechnology Health Care Medical Device Therapeutics

Founded:
2003-01-01

Address:
Malvern, Pennsylvania, United States

Country:
United States

Website Url:
http://www.neurostar.com

Total Employee:
101+

Status:
Active

Contact:
877-600-7555

Email Addresses:
[email protected]

Total Funding:
313.4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome


Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

agenus-logo

Agenus

Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

cadent-therapeutics-logo

Cadent Therapeutics

Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

photometics-logo

Photometics

Photometics develops infrared light-based therapy for skin cancer.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.


Current Advisors List

bruce-shook_image

Bruce Shook Director, Chair Nominating & Corporate Governance Committee @ Neuronetics
Board_member
2020-07-01

brian-farley_image

Brian Farley Board Member @ Neuronetics
Board_member
2016-01-01

stephen-campe_image

Stephen Campe Board Member @ Neuronetics
Board_member
2013-01-01

glenn-muir_image

Glenn Muir Board Member @ Neuronetics
Board_member
2017-08-01

wilfred-jaeger_image

Wilfred Jaeger Board Member @ Neuronetics
Board_member
2005-03-01

chris-thatcher_image

Chris Thatcher Board Member @ Neuronetics
Board_member

Current Employees Featured

charles-e-larsen_image

Charles E. Larsen
Charles E. Larsen Co-Founder @ Neuronetics
Co-Founder

steve-mackinnon_image

Steve MacKinnon
Steve MacKinnon Vice President of Sales @ Neuronetics
Vice President of Sales

judy-p-ways_image

Judy P. Ways
Judy P. Ways Vice President, Regulatory Affairs and Quality Assurance @ Neuronetics
Vice President, Regulatory Affairs and Quality Assurance
2003-04-01

cory-anderson_image

Cory Anderson
Cory Anderson VP Clinical Affairs and Medical Operations @ Neuronetics
VP Clinical Affairs and Medical Operations
2021-03-01

not_available_image

Charles Epstein
Charles Epstein Co-Founder & Managing Director @ Neuronetics
Co-Founder & Managing Director

keith-sullivan_image

Keith Sullivan
Keith Sullivan President and CEO @ Neuronetics
President and CEO
2020-07-01

matthew-rieke_image

Matthew Rieke
Matthew Rieke Investor @ Neuronetics
Investor

daniel-guthrie_image

Daniel Guthrie
Daniel Guthrie Chief Commercial Officer @ Neuronetics
Chief Commercial Officer

Founder


charles-e-larsen_image

Charles E. Larsen

not_available_image

Charles Epstein

norman-weldon_image

Norman Weldon

Stock Details


Company's stock symbol is NASDAQ:STIM

Investors List

j-carlo-cannell_image

J Carlo Cannell

J Carlo Cannell investment in Post-IPO Equity - Neuronetics

meeschaert-capital-partners_image

Solar capital

Solar capital investment in Post-IPO Debt - Neuronetics

investor-growth-capital_image

Investor Growth Capital Limited

Investor Growth Capital Limited investment in Series G - Neuronetics

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Series G - Neuronetics

accuitive-medical-ventures_image

Accuitive Medical Ventures

Accuitive Medical Ventures investment in Series G - Neuronetics

industry-ventures_image

Industry Ventures

Industry Ventures investment in Series G - Neuronetics

onset-ventures_image

ONSET Ventures

ONSET Ventures investment in Series G - Neuronetics

ge-ventures_image

GE Ventures

GE Ventures investment in Series G - Neuronetics

kbl-healthcare-ventures_image

KBL Healthcare Ventures

KBL Healthcare Ventures investment in Series G - Neuronetics

pfizer-venture-investments_image

Pfizer Venture Investments

Pfizer Venture Investments investment in Series G - Neuronetics

Official Site Inspections

http://www.neurostar.com Semrush global rank: 686.07 K Semrush visits lastest month: 61.79 K

  • Host name: 64.91.240.150
  • IP address: 64.91.240.150
  • Location: Lansing United States
  • Latitude: 42.7348
  • Longitude: -84.6245
  • Metro Code: 551
  • Timezone: America/Detroit
  • Postal: 48917

Loading ...

More informations about "Neuronetics" on Search Engine